Navigation Links
Longer Lung Cancer Survival

According to the American Cancer Society, there are 172,000 Americans diagnosed with lung cancer each year. Because there are no early screening tests, many of these cancers are caught in their later stages, making them difficult to treat. A new drug is now helping patients who have failed standard treatment.
By going after that protein, the drug stops the cancer from growing. Studies show as many as 20 percent of patients //taking the drug actually had their tumors shrink by 50 percent or more. Another 35 percent had symptoms relieved.
Marcie has stage four lung cancer.Her first dose of chemotherapy didn’t work. More chemo and radiation followed, but her cancer didn’t go away. She says, "You want to hear words of encouragement and hope. You know, you just long for something."

Those words of hope came when she met Oncologist Karen Kelly, M.D., who introduced her to a promising drug called ZD-1839. ZD-1839, specifically targets a specific protein on a cancer cell,Says Dr. Kelly, of University of Colorado Health Sciences Center in Denver.

Dr. Kelly says, "It really provides them with a chance to have prolonged survival with a high quality of life. It’s not a magic bullet, but it really has helped a lot of patients with lung cancer."

Marcie takes the drug every day. She says, "This drug has given me renewed life and renewed hope and renewed faith. I live now with a love of life and enjoy every day and try not to take any day for granted." With more energy and more strength, she’s able to live life to the fullest.

On May 5, 2003, the FDA approved this drug for advanced stage lung cancer under the name Iressa. The major side effect of the drug is a mild skin rash, which can be treated with medication if needed. It is currently only offered to patients who have failed at least two different treatments of chemotherapy. The drug is given once a day in tablet form.

If you would like more information, plea se contact:

Tina Russell, R.N., OCM
Oncology Certified Nurse
University of Colorado Health Sciences Center
4200 East 9th Ave., B171
Denver, CO 80262
(720) 848-024
'"/>




Related medicine news :

1. Longer airway in males increases sleep disorder risk
2. Patients Are Given Catheter Longer Than Necessary
3. Fat Patients Require Longer Needles
4. Patients In Ontario Wait Longer For Treatment
5. Quality Platelets and Improved Blood Availability No Longer a Pipe Dream
6. Oscar Winners Live Longer Than Co-Competitors
7. Threat from Chikungunya, No Longer a Fear
8. Cyber Sex, No Longer A Fantasy Of The Mind
9. Kids Face a Slim Chance of Growing Obese, If Breastfed Longer Than Three Months
10. Misleading Health Claims On Food Labels No Longer Allowed in EU
11. Slow Learners Have Longer Memories
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... ... May 24, 2016 , ... Women's ... , Roberta Jordan is a Certified Nurse Midwife who was born and raised ... then went on to complete her masters degree from the University of Mexico. ...
(Date:5/24/2016)... ... 24, 2016 , ... Educational opportunities, and therefore life chances, ... communities providing richer opportunities. Recognizing the key role of housing in this system, ... school choice policies; (c) school desegregation policies; (d) wealth-focused policies; and (e) housing-focused ...
(Date:5/24/2016)... ... 24, 2016 , ... Regenerative Medicine is being transformed by ongoing research and ... protocols and patient results as have been achieved with Okyanos Cell Therapy ... of care for patients worldwide. , As the Medical Advisory Chairman at Okyanos, Eric ...
(Date:5/24/2016)... ... 2016 , ... Backed by decades of experience, Metroloji Okulu ... the best suited solution to meet regulatory requirements. Their professional staff also performs ... Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical and pharmaceutical ...
(Date:5/24/2016)... ... May 24, 2016 , ... American Gene Technologies ... to its board of directors. Otterstatter is co-founder, president and CEO of ... technological innovations that lead to broad-based healthcare solutions. , “Jon knows how to ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und demonstriert ... in ‚ausgezeichneter plus guter , ...    ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... heute neue positive Daten von der MORA-Studie der ...
(Date:5/24/2016)... LAWRENCE, Mass. , May 24, 2016  NxStage ... medical technology company focused on advancing renal care, today ... Officer, plans to participate in the following schedule of ... will be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, ...
(Date:5/24/2016)... , May 24, 2016 ... de doble terapia del mundo, introduce catéteres para ... OrbusNeich, una compañía global especializada en ... vidas, ha expandido su cartera incluyendo productos para ... JADE™ y Scoreflex™ PTA son los dispositivos de ...
Breaking Medicine Technology: